5-fluoropyrimidine has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schöffski, P | 1 |
| Peeters, M; Van Cutsem, E | 1 |
2 review(s) available for 5-fluoropyrimidine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dosage Forms; Drug Administration Schedule; Drug Combinations; Drug Delivery Systems; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Oxonic Acid; Prodrugs; Pyridines; Pyrimidines; Tegafur | 2004 |
Developments in fluoropyrimidine therapy for gastrointestinal cancer.
Topics: Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Pyrimidines | 1999 |